Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Accumulated Expenses (2020 - 2025)

Historic Accumulated Expenses for KORU Medical Systems (KRMD) over the last 10 years, with Q3 2025 value amounting to $4.6 million.

  • KORU Medical Systems' Accumulated Expenses rose 6592.33% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 6592.33%. This contributed to the annual value of $3.9 million for FY2024, which is 12929.31% up from last year.
  • Latest data reveals that KORU Medical Systems reported Accumulated Expenses of $4.6 million as of Q3 2025, which was up 6592.33% from $3.6 million recorded in Q2 2025.
  • Over the past 5 years, KORU Medical Systems' Accumulated Expenses peaked at $4.6 million during Q3 2025, and registered a low of $1.4 million during Q2 2023.
  • For the 5-year period, KORU Medical Systems' Accumulated Expenses averaged around $2.5 million, with its median value being $2.1 million (2024).
  • Its Accumulated Expenses has fluctuated over the past 5 years, first tumbled by 4322.02% in 2023, then soared by 17257.59% in 2025.
  • Quarter analysis of 5 years shows KORU Medical Systems' Accumulated Expenses stood at $2.7 million in 2021, then increased by 6.65% to $2.9 million in 2022, then plummeted by 40.78% to $1.7 million in 2023, then skyrocketed by 129.29% to $3.9 million in 2024, then grew by 18.09% to $4.6 million in 2025.
  • Its Accumulated Expenses was $4.6 million in Q3 2025, compared to $3.6 million in Q2 2025 and $4.0 million in Q1 2025.